[go: up one dir, main page]

HK1165200A - Chimeric newcastle disease viruses and uses thereof - Google Patents

Chimeric newcastle disease viruses and uses thereof Download PDF

Info

Publication number
HK1165200A
HK1165200A HK12105757.8A HK12105757A HK1165200A HK 1165200 A HK1165200 A HK 1165200A HK 12105757 A HK12105757 A HK 12105757A HK 1165200 A HK1165200 A HK 1165200A
Authority
HK
Hong Kong
Prior art keywords
newcastle disease
disease viruses
chimeric newcastle
viruses
chimeric
Prior art date
Application number
HK12105757.8A
Other languages
Chinese (zh)
Inventor
Dmitriy Zamarin
Adolfo Garcia-Sastre
Peter Palese
Yuman Fong
Original Assignee
Mount Sinai School Of Medicine
Memorial Sloan-Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School Of Medicine, Memorial Sloan-Kettering Cancer Center filed Critical Mount Sinai School Of Medicine
Publication of HK1165200A publication Critical patent/HK1165200A/en

Links

Abstract

Described herein are chimeric Newcastle disease viruses engineered to express a heterologous interferon antagonist and compositions comprising such viruses. The chimeric Newcastle disease viruses and compositions are useful in the treatment of cancer.
HK12105757.8A 2009-02-05 2010-02-05 Chimeric newcastle disease viruses and uses thereof HK1165200A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/150,285 2009-02-05

Publications (1)

Publication Number Publication Date
HK1165200A true HK1165200A (en) 2012-09-28

Family

ID=

Similar Documents

Publication Publication Date Title
WO2010091262A8 (en) Chimeric newcastle disease viruses and uses thereof
IL281111A (en) Compositions for conferring tolerance to viral disease in social insects, and the use thereof
IL219865A0 (en) Acid salt forms of polymer-drug conjugates, compositions comprising the same, methods of producing the same and uses thereof
IL216508A (en) Vaccines against herpes simplex virus type 1 and/or type 2 and compositions and uses thereof
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
IL232716A (en) Oligomeric phosphonates and compositions including the same
SI2461833T1 (en) Vaccine composition comprising 5'-cap modified rna
MX362089B (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof.
WO2014158811A8 (en) Newcastle disease viruses and uses thereof
IL219876A (en) Antibody or fragment thereof against human b7-h1, compositions comprising same and use thereof in the preparation of medicaments
EP2413901A4 (en) Polymer-agent conjugates, particles, compositions, and related methods of use
IL217392A0 (en) Pegylated l-asparaginase conjugates, compositions comprising the same and uses thereof
SI2627334T1 (en) Compositions for use in the treatment of viral infections
IL217278A0 (en) Nucleic acid - lipid particles, compositions comprising the same and uses thereof
PL2473636T3 (en) Type 1 interferon diagnostic
AP2011005800A0 (en) Purified plasmodium and vaccine compositions.
IL226023A0 (en) Anti-dr5 antibodies, compositions comprising the same and uses thereof
WO2011150190A3 (en) Hcv inhibitor compounds and methods of use thereof
IL209027A0 (en) Vaccine compositions and uses thereof
ZA201004337B (en) Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing the same
MX2011008179A (en) Peptides for vaccine.
AU326911S (en) Vacuum cleaner
EP3150632A3 (en) Anti-ricin antibodies and uses thereof
EP3456837A3 (en) Decorin compositions and use thereof
IL218869A0 (en) Oligomer-calcimimetic conjugates,compositions comprising the same and uses thereof